Testicular Cancer (Germ Cell Tumors)

The testicular cancer program at Winship Cancer Institute of Emory University in Atlanta, GA offers the only and advanced treatment for testicle cancer patients (including genitourinary cancer) in Georgia and the Southeast.

What is Cancer of the Testes?

The testes are part of the reproductive and endocrine systems and are responsible for producing sperm and male sex hormones (most commonly, testosterone).

They are normally round and are suspended inside a pouch (scrotum) that hangs under the penis, outside the body cavity. At the top of each testis is a bunch of tiny tubules that collect and store sperm. This structure is called the epididymis. The sperm travel from the epididymis through the spermatic cord (or vas deferens) and out through the urethra during ejaculation.

Testicular cancer is rare in the general population, responsible for only 1–2 percent of all cancers in men. Nevertheless, it is the most common cancer in men aged 20–35, occurring in four of every 100,000 men.

When testicular cancer is detected at an early stage, it is very treatable, with a cure rate approaching 99 percent.

Survival Outcomes

Our data show that over 60% of our patients treated for relapsed/refractory testicular cancer with an autolgous transplant, have a steady survival rate beyond year one.

 Survival Outcomes, Testicular Cancer Autologous 2007-2011

testicular cancer graph

 

 

National awards & recognition

Awards

• Winship is a National Cancer Institute - Designated Cancer Center
• US News & World Report “America’s Best Hospitals"
• Accredited by the American College of Surgeons Commission on Cancer
• Joint Commission on Accreditation of Healthcare Organizations
• Blue Cross Distinction - Center for Complex and Rare Cancers
• OptumHealth Center of Excellence for Bone Marrow Transplant
• Foundation for the Accreditation of Cell Therapy (FACT) Accredited
• Center of Excellence of the Myelodysplastic Syndromes Foundation.